Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage

Yue Shi,1 Xuehui Fan,1 Guozhong Li,1 Di Zhong,1 Xin Zhang2 1Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, People’s Republic of China; 2Department of Neurology, Liuzhou People’s Hospital, Liuzhou, Guangxi...

Full description

Bibliographic Details
Main Authors: Shi Y, Fan X, Li G, Zhong D, Zhang X
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Online Access:https://www.dovepress.com/association-of-serum-dystroglycan-mmp-29-and-aqp-4-with-haematoma-expa-peer-reviewed-article-NDT
_version_ 1830301972604911616
author Shi Y
Fan X
Li G
Zhong D
Zhang X
author_facet Shi Y
Fan X
Li G
Zhong D
Zhang X
author_sort Shi Y
collection DOAJ
description Yue Shi,1 Xuehui Fan,1 Guozhong Li,1 Di Zhong,1 Xin Zhang2 1Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, People’s Republic of China; 2Department of Neurology, Liuzhou People’s Hospital, Liuzhou, Guangxi, 545006, People’s Republic of ChinaCorrespondence: Xin ZhangDepartment of Neurology, Liuzhou People’s Hospital, 8 Wenchang Road, Liuzhou, Guangxi 545006, People’s Republic of ChinaTel +86-13946027603Email zhangxinxueshu123@163.comObjective: The purpose of this study was to explore association of serum dystroglycan (DG), matrix metalloproteinase-2/matrix metalloproteinase-9 (MMP-2/9), and aquaporin-4 (AQP-4) expression and haematoma expansion in patients with intracerebral haemorrhage (ICH), which are proteins involved in maintaining the integrity of the blood-brain barrier.Methods: We included patients older than 18 years old with ICH who had undergone baseline CT within 6 hours after intracerebral haemorrhage symptom onset in our hospital between April 2018 and December 2018. Two readers independently assessed haematoma volume and other imaging information upon admission and again within 24 hours. All patients underwent 5 mL of venous blood collection 6 and 24 hours after admission. Serum expression levels of dystroglycan, matrix metalloproteinase-2/matrix metalloproteinase-9 and aquaporin-4 were determined by quantitative enzyme-linked immunosorbent assay (ELISA). Repeated analysis of variance was used to determine whether expression of the four proteins in patients with cerebral haemorrhage changed within 24 hours and whether there were differences between the haematoma enlargement and non-haematoma enlargement groups over time. Univariate and multivariate logistic regression analyses were used to compare the correlation among expression of the four proteins, clinical characteristics of patients and haematoma enlargement.Results: Expression levels of serum matrix metalloproteinase-2/matrix metalloproteinases-9 and aquaporin-4 gradually increased within 24 hours in patients with cerebral haemorrhage (P< 0.001), while expression levels of dystroglycan gradually decreased (P< 0.01). Expression of serum matrix metalloproteinases-9 6 hours after onset was independently correlated with the expansion of cerebral haemorrhage. The ROC curve (AUC=0.778, 95% Cl: 0.661– 0.894, P< 0.001) exhibited high sensitivity (0.900) and low specificity (0.642).Conclusion: These data support that expression of MMP-9 in peripheral blood is independently correlated with the enlargement of haematoma in patients with intracerebral haemorrhage 6 hours after onset and can be used as an independent predictor of haematoma enlargement in patients with intracerebral haemorrhage. However, although the expression of MMP-2, AQP-4 and DG exhibited some changes within 6 and 24 hours after onset, they were not independently correlated with early haematoma enlargement in patients with intracerebral haemorrhage. Further multi-time point exploration and expansion of the sample size is necessary in future studies.Keywords: intracerebral hemorrhage, ICH, hematoma enlargement, HE, dystroglycan, DG, matrix metalloproteinase-2/9, MMP-2/9, aquaporin-4, AQP-4
first_indexed 2024-12-19T08:57:54Z
format Article
id doaj.art-7dc0e4711671424398100f1efadb9540
institution Directory Open Access Journal
issn 1178-2021
language English
last_indexed 2024-12-19T08:57:54Z
publishDate 2021-01-01
publisher Dove Medical Press
record_format Article
series Neuropsychiatric Disease and Treatment
spelling doaj.art-7dc0e4711671424398100f1efadb95402022-12-21T20:28:33ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212021-01-01Volume 17111860927Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral HaemorrhageShi YFan XLi GZhong DZhang XYue Shi,1 Xuehui Fan,1 Guozhong Li,1 Di Zhong,1 Xin Zhang2 1Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, People’s Republic of China; 2Department of Neurology, Liuzhou People’s Hospital, Liuzhou, Guangxi, 545006, People’s Republic of ChinaCorrespondence: Xin ZhangDepartment of Neurology, Liuzhou People’s Hospital, 8 Wenchang Road, Liuzhou, Guangxi 545006, People’s Republic of ChinaTel +86-13946027603Email zhangxinxueshu123@163.comObjective: The purpose of this study was to explore association of serum dystroglycan (DG), matrix metalloproteinase-2/matrix metalloproteinase-9 (MMP-2/9), and aquaporin-4 (AQP-4) expression and haematoma expansion in patients with intracerebral haemorrhage (ICH), which are proteins involved in maintaining the integrity of the blood-brain barrier.Methods: We included patients older than 18 years old with ICH who had undergone baseline CT within 6 hours after intracerebral haemorrhage symptom onset in our hospital between April 2018 and December 2018. Two readers independently assessed haematoma volume and other imaging information upon admission and again within 24 hours. All patients underwent 5 mL of venous blood collection 6 and 24 hours after admission. Serum expression levels of dystroglycan, matrix metalloproteinase-2/matrix metalloproteinase-9 and aquaporin-4 were determined by quantitative enzyme-linked immunosorbent assay (ELISA). Repeated analysis of variance was used to determine whether expression of the four proteins in patients with cerebral haemorrhage changed within 24 hours and whether there were differences between the haematoma enlargement and non-haematoma enlargement groups over time. Univariate and multivariate logistic regression analyses were used to compare the correlation among expression of the four proteins, clinical characteristics of patients and haematoma enlargement.Results: Expression levels of serum matrix metalloproteinase-2/matrix metalloproteinases-9 and aquaporin-4 gradually increased within 24 hours in patients with cerebral haemorrhage (P< 0.001), while expression levels of dystroglycan gradually decreased (P< 0.01). Expression of serum matrix metalloproteinases-9 6 hours after onset was independently correlated with the expansion of cerebral haemorrhage. The ROC curve (AUC=0.778, 95% Cl: 0.661– 0.894, P< 0.001) exhibited high sensitivity (0.900) and low specificity (0.642).Conclusion: These data support that expression of MMP-9 in peripheral blood is independently correlated with the enlargement of haematoma in patients with intracerebral haemorrhage 6 hours after onset and can be used as an independent predictor of haematoma enlargement in patients with intracerebral haemorrhage. However, although the expression of MMP-2, AQP-4 and DG exhibited some changes within 6 and 24 hours after onset, they were not independently correlated with early haematoma enlargement in patients with intracerebral haemorrhage. Further multi-time point exploration and expansion of the sample size is necessary in future studies.Keywords: intracerebral hemorrhage, ICH, hematoma enlargement, HE, dystroglycan, DG, matrix metalloproteinase-2/9, MMP-2/9, aquaporin-4, AQP-4https://www.dovepress.com/association-of-serum-dystroglycan-mmp-29-and-aqp-4-with-haematoma-expa-peer-reviewed-article-NDTintracerebral hemorrhage (ich)hematoma enlargement (he)dystroglycan(dg)matrixmetalloproteinase-2/9(mmp-2/9)aquaporin-4(aqp-4)
spellingShingle Shi Y
Fan X
Li G
Zhong D
Zhang X
Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
Neuropsychiatric Disease and Treatment
intracerebral hemorrhage (ich)
hematoma enlargement (he)
dystroglycan(dg)
matrixmetalloproteinase-2/9(mmp-2/9)
aquaporin-4(aqp-4)
title Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
title_full Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
title_fullStr Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
title_full_unstemmed Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
title_short Association of Serum Dystroglycan, MMP-2/9 and AQP-4 with Haematoma Expansion in Patients with Intracerebral Haemorrhage
title_sort association of serum dystroglycan mmp 2 9 and aqp 4 with haematoma expansion in patients with intracerebral haemorrhage
topic intracerebral hemorrhage (ich)
hematoma enlargement (he)
dystroglycan(dg)
matrixmetalloproteinase-2/9(mmp-2/9)
aquaporin-4(aqp-4)
url https://www.dovepress.com/association-of-serum-dystroglycan-mmp-29-and-aqp-4-with-haematoma-expa-peer-reviewed-article-NDT
work_keys_str_mv AT shiy associationofserumdystroglycanmmp29andaqp4withhaematomaexpansioninpatientswithintracerebralhaemorrhage
AT fanx associationofserumdystroglycanmmp29andaqp4withhaematomaexpansioninpatientswithintracerebralhaemorrhage
AT lig associationofserumdystroglycanmmp29andaqp4withhaematomaexpansioninpatientswithintracerebralhaemorrhage
AT zhongd associationofserumdystroglycanmmp29andaqp4withhaematomaexpansioninpatientswithintracerebralhaemorrhage
AT zhangx associationofserumdystroglycanmmp29andaqp4withhaematomaexpansioninpatientswithintracerebralhaemorrhage